Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study

Affiliations

• ¹ Department of Dermatology, Liverpool Hospital, Sydney, Australia; Laboratory of Translational Cutaneous Medicine, Ingham Institute, Sydney, Australia; School of Clinical Medicine, University of New South Wales, Sydney, Australia.
• ² Department of Dermatology, Liverpool Hospital, Sydney, Australia; Laboratory of Translational Cutaneous Medicine, Ingham Institute, Sydney, Australia.
• ³ Department of Dermatology, Liverpool Hospital, Sydney, Australia; Laboratory of Translational Cutaneous Medicine, Ingham Institute, Sydney, Australia; School of Clinical Medicine, University of New South Wales, Sydney, Australia. Electronic address: [email protected].